Related references
Note: Only part of the references are listed.Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activity
Praveen Rajendran et al.
INVESTIGATIONAL NEW DRUGS (2008)
Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-O-(3′,3′-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection
Patrick F. Smith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Novel semisynthetic analogues of betulinic acid with diverse cytoprotective, antiproliferative, and proapoptotic activities
Karen Liby et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors
Sudhakar Chintharlapalli et al.
CANCER RESEARCH (2007)
Synthesis and cytotoxic activity of 17-carboxylic acid modified 23-hydroxy betulinic acid ester derivatives
Yi Bi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
Multiple-dose pharmacokinetics and safety of bevirimat, a novel inhibitor of HIV maturation, in healthy volunteers
David E. Martin et al.
CLINICAL PHARMACOKINETICS (2007)
Mitochondria as therapeutic targets for cancer chemotherapy
L. Galluzzi et al.
ONCOGENE (2006)
Pharmacological properties of the ubiquitous natural product betulin
Sami Alakurtti et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Betulinic acid as new activator of NF-κB:: molecular mechanisms and implications for cancer therapy
H Kasperczyk et al.
ONCOGENE (2005)
Sensitization for anticancer drug-induced apoptosis by betulinic acid
S Fulda et al.
NEOPLASIA (2005)
Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice
N Sawada et al.
BRITISH JOURNAL OF CANCER (2004)
Toxic proteins released from mitochondria in cell death
X Saelens et al.
ONCOGENE (2004)
Betulinic acid-induced apoptosis in leukemia cells
H Ehrhardt et al.
LEUKEMIA (2004)
The pathophysiology of mitochondrial cell death
DR Green et al.
SCIENCE (2004)
Synthesis of 3-O-acyl/3-benzylidene/3-hydrazone/3-hydrazine/17-carboxyacryloyl ester derivatives of betulinic acid as anti-angiogenic agents
R Mukherjee et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Targeting apoptosis pathways in cancer therapy
S Fulda et al.
CURRENT CANCER DRUG TARGETS (2004)
Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection
RH Cichewicz et al.
MEDICINAL RESEARCH REVIEWS (2004)
Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells
S Fulda et al.
ONCOGENE (2004)
New lupane derived compounds with pro-apoptotic activity in cancer cells:: Synthesis and structure -: Activity relationships
J Sarek et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Synthesis and cytotoxic activity of A-ring modified betulinic acid derivatives
YJ You et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Betulinic acid suppresses carcinogen-induced NF-κB activation through inhibition of IκBα kinase and p65 phosphorylation:: Abrogation of cyclooxygenase-2 and matrix metalloprotease-9
Y Takada et al.
JOURNAL OF IMMUNOLOGY (2003)
Betulinic acid: A new cytotoxic compound against malignant head and neck cancer cells
D Thurnher et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2003)
Natural products as sources of new drugs over the period 1981-2002
DJ Newman et al.
JOURNAL OF NATURAL PRODUCTS (2003)
Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells
N André et al.
FEBS LETTERS (2002)
IAP proteins: Blocking the road to death's door
GS Salvesen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Betulinic acid inhibits growth factor-induced in vitro angiogenesis via the modulation of mitochondrial function in endothelial cells
HJ Kwon et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2002)
Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells
V Zuco et al.
CANCER LETTERS (2002)
Development of C-20 modified betulinic acid derivatives as antitumor agents
JY Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocytic naeval cells: evidence for a potential role as a chemopreventive agent
GI Salti et al.
MELANOMA RESEARCH (2001)
p53-Independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-γ
RD Meng et al.
EXPERIMENTAL CELL RESEARCH (2001)
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems
H Walczak et al.
EXPERIMENTAL CELL RESEARCH (2000)
Effects of betulinic acid alone and in combination with irradiation in human melanoma cells
E Selzer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
Share Paper
